236 related articles for article (PubMed ID: 24588265)
1. Identification of hematopoietic progenitor cell donor characteristics predicting successful mobilization: results of an Italian multicenter study.
Bertani G; Santoleri L; Martino M; Fedele R; Moscato T; Marenco P; Grillo G; Zucchetti E; Lotesoriere I; Lando G; Cesana C; Cairoli R; Rossini S
Transfusion; 2014 Aug; 54(8):2028-33. PubMed ID: 24588265
[TBL] [Abstract][Full Text] [Related]
2. Preharvest hematopoietic progenitor cell counts predict CD34+ cell yields in granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell harvest in healthy donors.
Yang SH; Wang TF; Tsai HH; Lin TY; Wen SH; Chen SH
Transfusion; 2010 May; 50(5):1088-95. PubMed ID: 20051055
[TBL] [Abstract][Full Text] [Related]
3. High-versus standard-dose filgrastim (rhG-CSF) for mobilization of peripheral-blood progenitor cells from allogeneic donors and CD34(+) immunoselection.
Engelhardt M; Bertz H; Afting M; Waller CF; Finke J
J Clin Oncol; 1999 Jul; 17(7):2160-72. PubMed ID: 10561272
[TBL] [Abstract][Full Text] [Related]
4. Peripheral blood stem cell yield in 400 normal donors mobilised with granulocyte colony-stimulating factor (G-CSF): impact of age, sex, donor weight and type of G-CSF used.
Ings SJ; Balsa C; Leverett D; Mackinnon S; Linch DC; Watts MJ
Br J Haematol; 2006 Sep; 134(5):517-25. PubMed ID: 17018030
[TBL] [Abstract][Full Text] [Related]
5. Reduced dose of lenograstim is as efficacious as standard dose of filgrastim for peripheral blood stem cell mobilization and transplantation: a randomized study in patients undergoing autologous peripheral stem cell transplantation.
Ataergin S; Arpaci F; Turan M; Solchaga L; Cetin T; Ozturk M; Ozet A; Komurcu S; Ozturk B
Am J Hematol; 2008 Aug; 83(8):644-8. PubMed ID: 18508321
[TBL] [Abstract][Full Text] [Related]
6. GM-CSF-based mobilization effect in normal healthy donors for allogeneic peripheral blood stem cell transplantation.
Sohn SK; Kim JG; Seo KW; Chae YS; Jung JT; Suh JS; Lee KB
Bone Marrow Transplant; 2002 Jul; 30(2):81-6. PubMed ID: 12132046
[TBL] [Abstract][Full Text] [Related]
7. Second donation of granulocyte-colony-stimulating factor-mobilized peripheral blood progenitor cells: risk factors associated with a low yield of CD34+ cells.
Platzbecker U; Bornhäuser M; Zimmer K; Lerche L; Rutt C; Ehninger G; Hölig K
Transfusion; 2005 Jan; 45(1):11-5. PubMed ID: 15647012
[TBL] [Abstract][Full Text] [Related]
8. Superior mobilisation of haematopoietic progenitor cells with glycosylated G-CSF in male but not female unrelated stem cell donors.
Fischer JC; Frick M; Wassmuth R; Platz A; Punzel M; Wernet P
Br J Haematol; 2005 Sep; 130(5):740-6. PubMed ID: 16115131
[TBL] [Abstract][Full Text] [Related]
9. Peripheral blood circulating immature cell counts predict CD34+ cell yields in G-CSF-induced PBPC mobilization in healthy donors.
Kozuka T; Ikeda K; Teshima T; Yoshida C; Shinagawa K; Kojima K; Matsuo K; Bessho A; Sunami K; Hiramatsu Y; Maeda Y; Noguchi T; Yamamoto K; Fujii N; Imai T; Kusumoto KK; Masuda K; Takenaka K; Ishimaru F; Niiya K; Koide N; Tanimoto M; Harada M
Transfusion; 2004 Apr; 44(4):526-32. PubMed ID: 15043568
[TBL] [Abstract][Full Text] [Related]
10. Factors associated with granulocyte colony-stimulating factor-induced peripheral blood stem cell yield in healthy donors.
Suzuya H; Watanabe T; Nakagawa R; Watanabe H; Okamoto Y; Onishi T; Abe T; Kawano Y; Kagami S; Takaue Y
Vox Sang; 2005 Nov; 89(4):229-35. PubMed ID: 16262756
[TBL] [Abstract][Full Text] [Related]
11. Donor body mass index is an important factor that affects peripheral blood progenitor cell yield in healthy donors after mobilization with granulocyte-colony-stimulating factor.
Chen J; Burns KM; Babic A; Carrum G; Kennedy M; Segura FJ; Garcia S; Potts S; Leveque C
Transfusion; 2014 Jan; 54(1):203-10. PubMed ID: 23763340
[TBL] [Abstract][Full Text] [Related]
12. [Collection of hematopoietic progenitor cells from healthy donors].
Bojanić I; Cepulić BG; Mazić S
Acta Med Croatica; 2009 Jun; 63(3):237-44. PubMed ID: 19827352
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and toxicity of a high-dose G-CSF schedule for peripheral blood progenitor cell mobilization in healthy donors.
Martínez C; Urbano-Ispizua A; Marín P; Merino A; Rovira M; Carreras E; Montserrat E
Bone Marrow Transplant; 1999 Dec; 24(12):1273-8. PubMed ID: 10627634
[TBL] [Abstract][Full Text] [Related]
14. Biosimilar G-CSF versus filgrastim and lenograstim in healthy unrelated volunteer hematopoietic stem cell donors.
Farhan R; Urbanowska E; Zborowska H; Król M; Król M; Torosian T; Piotrowska I; Bogusz K; Skwierawska K; Wiktor-Jędrzejczak W; Snarski E
Ann Hematol; 2017 Oct; 96(10):1735-1739. PubMed ID: 28801752
[TBL] [Abstract][Full Text] [Related]
15. Stem cell mobilisation with 16 microg/kg vs 10 microg/kg of G-CSF for allogeneic transplantation in healthy donors.
Kröger N; Renges H; Sonnenberg S; Krüger W; Gutensohn K; Dielschneider T; Cortes-Dericks L; Zander AR
Bone Marrow Transplant; 2002 May; 29(9):727-30. PubMed ID: 12040468
[TBL] [Abstract][Full Text] [Related]
16. Correlations between hematopoietic progenitor cell counts as measured by Sysmex and CD34+ cell harvest yields following mobilization with different regimens.
Vogel W; Kopp HG; Kanz L; Einsele H
J Cancer Res Clin Oncol; 2002 Jul; 128(7):380-4. PubMed ID: 12136252
[TBL] [Abstract][Full Text] [Related]
17. Predictive factors that affect the mobilization of CD34(+) cells in healthy donors treated with recombinant granulocyte colony-stimulating factor (G-CSF).
Martino M; Callea I; Condemi A; Dattola A; Irrera G; Marcuccio D; Messina G; Pontari A; Pucci G; Console G; Lacopino P
J Clin Apher; 2006 Oct; 21(3):169-75. PubMed ID: 16532489
[TBL] [Abstract][Full Text] [Related]
18. Lenograstim compared to filgrastim for the mobilization of hematopoietic stem cells in healthy donors.
Pérez-López O; Martín-Sánchez J; Parody-Porras R; Espigado-Tocino I; Noguerol P; Carmona-González M; Pérez-Simón JA
Transfusion; 2013 Dec; 53(12):3240-2. PubMed ID: 23489237
[TBL] [Abstract][Full Text] [Related]
19. Analysis of stem cell apheresis products using intermediate-dose filgrastim plus large volume apheresis for allogeneic transplantation.
Engelhardt M; Bertz H; Wäsch R; Finke J
Ann Hematol; 2001 Apr; 80(4):201-8. PubMed ID: 11401085
[TBL] [Abstract][Full Text] [Related]
20. Clinical usefulness of the hematopoietic progenitor cell counts in predicting the optimal timing of peripheral blood stem cell harvest.
Lee JL; Kim SB; Lee GW; Ryu MH; Kim EK; Kim S; Kim WK; Lee JS; Park KU; Suh C
J Korean Med Sci; 2003 Feb; 18(1):27-35. PubMed ID: 12589083
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
